Related Experiment Video
Updated: Nov 9, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The Kidney-Heart Connection in Obesity
Almudena García-Carrasco1, Adriana Izquierdo-Lahuerta1, Gema Medina-Gómez1
1Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, Spain.
Insights
Obesity worsens cardiorenal syndrome (CRS) by causing adipose tissue dysfunction and inflammation, leading to cardiorenal metabolic syndrome (CRMetS). Further research is crucial to understand CRMetS amid the global obesity epidemic.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Syndrome
Background:
- Cardiorenal syndrome (CRS) involves a bidirectional relationship between heart and kidney failure, exacerbated by metabolic dysregulation.
- Obesity significantly worsens CRS, creating a cardiorenal metabolic syndrome (CRMetS) through adipose tissue dysfunction.
Purpose of the Study:
- To describe the contribution of obesity to the development of CRMetS.
- To elucidate the factors and mechanisms driving CRMetS.
Main Methods:
- Review of existing literature on cardiorenal interactions and metabolic syndrome.
- Analysis of mechanisms linking obesity, adipose tissue dysfunction, inflammation, and organ failure.
Main Results:
- Obesity induces adipose tissue dysfunction, leading to a lipotoxic state with inflammation, insulin resistance, dyslipidemia, oxidative stress, and hyperuricemia.
- Pro-inflammatory gut microbiota in obese individuals release uremic toxins, accelerating oxidative stress and inflammation.
Conclusions:
- Obesity is a critical factor in the progression of CRS to CRMetS.
- Understanding the complex interplay of factors in CRMetS is essential, particularly given the global obesity epidemic, necessitating further research.
Abstract:
There is a strong relationship between the kidney and the heart, where if one of these organs fails, so does the other, in the so-called cardiorenal syndrome (CRS). Besides, there are also interactions with the rest of the body leading to a metabolic state that establishes a feedback loop that is perpetuated. The CRS is characterized by hemodynamic changes, activation of neuro-humoral systems, natriuretic peptides, and changes in mineral metabolism. In this scenario, the kidney and heart, connected by a dysfunctional endothelium, inevitably fail. In obesity, this syndrome is exacerbated due to the complications of adipose tissue dysfunction, in the so-called cardiorenal metabolic syndrome (CRMetS). Obesity promotes adipose tissue dysfunction because it exceeds lipid storage capacity and leads to a lipotoxic state, characterized by inflammation, hypertension, insulin resistance and dyslipidemia, oxidative stress, and hyperuricemia, among others, that affect different organs other than the adipose tissue. In addition, the pro-inflammatory gut microbiota present in obese patients releases uremic toxins, contributing to oxidative stress and inflammation, perpetuating and accelerating the progression of this pathology. In this article, we describe the contribution of obesity, the factors and mechanisms implicated in the development of the CRMetS. Despite the great knowledge about the CRS, more research is needed to characterize the CRMetS given the global obesity epidemic.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
Related Concept Videos
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Kidney Transplant I: Introduction
Heart Failure Drugs: Diuretics
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Hypertension II: Pathophysiology